We have demonstrated that peri- or postoperative delivery of allochimeric [a1h u]-RT1.Aa class I major histocompatibility complex molecules with donor-type (RT1Au) immunogenic epitopes presented in recipient-type (RT1Aa) sequences induced donor-specific tolerance in ACI (RT1a) recipients of WF (RT1u) heart allografts. A genomic scan during the early posttransplant period was performed to elucidate the underlying operative mechanisms. A rat genome study after transplantation was carefully designed using Affymetrix Rat Genome 230 2.0 Array. The allochimeric treatment group is 3-day cyclosporine (CsA)-treated ACI recipients that accepted Wistar Furth RT1u cardiac allografts with postoperative dosage of allochimeric molecules, while the control is 3-day CsA-treated ACI recipients of WF cardiac allografts. All the samples were harvested 5 days after heart transplant as the early stage of tolerance detection. Following array data normalization and modeling, we compared the above two treatment groups and identified a total of 250 tolerance regulator genes induced by allochimeric molecules only.
|Original language||English (US)|
|Number of pages||2|
|State||Published - May 2005|
ASJC Scopus subject areas